title: Psychopharmacology.
abstract: Primary care providers (PCPs) are frequently responsible for the pharmacologic management of mood disorders, and the PCP is often an important member of the clinical team in the management of bipolar disorder and schizophrenia. Not only is a good understanding of psychopharmacology important for the effective treatment of psychiatric disease, it is also necessary for patient safety. Clinicians should understand the side effects and the medication interactions associated with psychotropic medications. This article reviews mechanisms of action, indications, dosing, side effects, medication interactions, and general management considerations for common medications used to treat psychiatric conditions encountered in the primary care setting.
authors.affiliation: Division of General Internal Medicine, Department of Medicine, Adult Medicine Clinic, Harborview Medical Center, University of Washington School of Medicine, 325 9th Avenue, Seattle, WA 98104, USA. Electronic address: lrenata@uw.edu.
authors.forename: L Renata
authors.initials: LR
authors.lastname: Thronson
authors.affiliation: Department of Medicine, Division of General Internal Medicine, Roosevelt General Internal Medicine Clinic, University of Washington Medical Center, 4245 Roosevelt Way North East, Seattle, WA 98105.
authors.forename: Genevieve L
authors.initials: GL
authors.lastname: Pagalilauan
mesh_terms: D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D062787:Drug Overdose; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D011320:Primary Health Care; D011619:Psychotropic Drugs / Q000008:administration & dosage* / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000927:Anticonvulsants; D003577:Cytochrome P-450 Enzyme System; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors
keywords: Antidepressant; Antipsychotic; Anxiety; Bipolar; Depression; Mood stabilizer; Primary care; Psychopharmacology